1. Home
  2. AVXL vs JBSS Comparison

AVXL vs JBSS Comparison

Compare AVXL & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • JBSS
  • Stock Information
  • Founded
  • AVXL 2004
  • JBSS 1959
  • Country
  • AVXL United States
  • JBSS United States
  • Employees
  • AVXL N/A
  • JBSS N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • JBSS Specialty Foods
  • Sector
  • AVXL Health Care
  • JBSS Consumer Staples
  • Exchange
  • AVXL Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • AVXL 750.3M
  • JBSS 794.3M
  • IPO Year
  • AVXL N/A
  • JBSS 1991
  • Fundamental
  • Price
  • AVXL $9.31
  • JBSS $69.21
  • Analyst Decision
  • AVXL Strong Buy
  • JBSS
  • Analyst Count
  • AVXL 2
  • JBSS 0
  • Target Price
  • AVXL $44.00
  • JBSS N/A
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • JBSS 62.0K
  • Earning Date
  • AVXL 05-08-2025
  • JBSS 04-30-2025
  • Dividend Yield
  • AVXL N/A
  • JBSS 4.50%
  • EPS Growth
  • AVXL N/A
  • JBSS N/A
  • EPS
  • AVXL N/A
  • JBSS 4.16
  • Revenue
  • AVXL N/A
  • JBSS $1,118,719,000.00
  • Revenue This Year
  • AVXL N/A
  • JBSS N/A
  • Revenue Next Year
  • AVXL N/A
  • JBSS N/A
  • P/E Ratio
  • AVXL N/A
  • JBSS $16.50
  • Revenue Growth
  • AVXL N/A
  • JBSS 12.09
  • 52 Week Low
  • AVXL $3.25
  • JBSS $65.29
  • 52 Week High
  • AVXL $14.44
  • JBSS $105.63
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 55.97
  • JBSS 49.95
  • Support Level
  • AVXL $8.61
  • JBSS $67.01
  • Resistance Level
  • AVXL $9.17
  • JBSS $69.44
  • Average True Range (ATR)
  • AVXL 0.67
  • JBSS 2.18
  • MACD
  • AVXL 0.09
  • JBSS 0.31
  • Stochastic Oscillator
  • AVXL 80.67
  • JBSS 82.18

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: